BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 28208659)

  • 1. Developmental Origins of Chronic Kidney Disease: Should We Focus on Early Life?
    Tain YL; Hsu CN
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental Programming of Adult Disease: Reprogramming by Melatonin?
    Tain YL; Huang LT; Hsu CN
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Renin-Angiotensin-Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins.
    Hsu CN; Tain YL
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between Oxidative Stress and Nutrient Sensing Signaling in the Developmental Origins of Cardiovascular Disease.
    Tain YL; Hsu CN
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Impact of Environmental Chemicals on Developmental Origins of Kidney Disease and Hypertension.
    Hsu CN; Tain YL
    Front Endocrinol (Lausanne); 2021; 12():745716. PubMed ID: 34721300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen Sulfide in Hypertension and Kidney Disease of Developmental Origins.
    Hsu CN; Tain YL
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Nitric Oxide Production in the Developmental Programming of Hypertension and Kidney Disease.
    Hsu CN; Tain YL
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30764498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMP-Activated Protein Kinase as a Reprogramming Strategy for Hypertension and Kidney Disease of Developmental Origin.
    Tain YL; Hsu CN
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in developmental programming of hypertension and renal diseases. Gender differences.
    Tomat AL; Salazar FJ
    Horm Mol Biol Clin Investig; 2014 May; 18(2):63-77. PubMed ID: 25390003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical basis for pharmacological intervention as a reprogramming strategy against hypertension and kidney disease of developmental origin.
    Tain YL; Chan SHH; Chan JYH
    Biochem Pharmacol; 2018 Jul; 153():82-90. PubMed ID: 29309755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal Fructose Intake Affects Transcriptome Changes and Programmed Hypertension in Offspring in Later Life.
    Tain YL; Chan JY; Hsu CN
    Nutrients; 2016 Nov; 8(12):. PubMed ID: 27897982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental Origins of Kidney Disease: Why Oxidative Stress Matters?
    Hsu CN; Tain YL
    Antioxidants (Basel); 2020 Dec; 10(1):. PubMed ID: 33396856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal Models for DOHaD Research: Focus on Hypertension of Developmental Origins.
    Hsu CN; Tain YL
    Biomedicines; 2021 May; 9(6):. PubMed ID: 34072634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition and Developmental Origins of Kidney Disease.
    Nguyen LT; Pollock CA; Saad S
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension.
    Tain YL; Hsu CN
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27918455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental Programming and Reprogramming of Hypertension and Kidney Disease: Impact of Tryptophan Metabolism.
    Hsu CN; Tain YL
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-Life Programming and Reprogramming of Adult Kidney Disease and Hypertension: The Interplay between Maternal Nutrition and Oxidative Stress.
    Hsu CN; Tain YL
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NOS/NO System in Renal Programming and Reprogramming.
    Tain YL; Hsu CN
    Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The First Thousand Days: Kidney Health and Beyond.
    Hsu CN; Tain YL
    Healthcare (Basel); 2021 Oct; 9(10):. PubMed ID: 34683012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: Sex specific programming: a critical role for the renal renin-angiotensin system.
    Moritz KM; Cuffe JS; Wilson LB; Dickinson H; Wlodek ME; Simmons DG; Denton KM
    Placenta; 2010 Mar; 31 Suppl():S40-6. PubMed ID: 20116093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.